In Utero Exposure to Bioactive Food Components and Mammary Cancer Risk (R21)
The summary for the In Utero Exposure to Bioactive Food Components and Mammary Cancer Risk (R21) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
In Utero Exposure to Bioactive Food Components and Mammary Cancer Risk (R21): The purpose of this initiative is to invite innovative preclinical R21 applications that promote research that will enhance the understanding of the relationship between exposures to bioactive food components and/or environmental chemicals in utero, hormonal and growth factor response, gene expression or epigenetic changes and subsequent mammary cancer risk in preclinical models. Although much evidence suggests that dietary components are linked to cancer prevention, the specific nutrients, sites of action, and role of exposure in utero remain elusive. Similarly, there are data suggesting a role for environmental agents, such as mycotoxins, heterocyclic amines, and environmental chemicals with endocrine activity in the etiology of mammary cancer, but for which the doses, windows of susceptibility and mechanisms are unclear. This funding opportunity encourages applications that apply new high-throughput genomic, epigenomic, proteomic, and metabolomic technologies to determine how dietary exposures in utero influence adult breast cancer susceptibility. The resulting information will help define effective maternal dietary intervention strategies for breast cancer prevention in her offspring.
Federal Grant Title: | In Utero Exposure to Bioactive Food Components and Mammary Cancer Risk (R21) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health Environment Education |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PA-06-277 |
Type of Funding: | Grant |
CFDA Numbers: | 93.11393.393 |
CFDA Descriptions: | Biological Response to Environmental Health Hazards 93.393 Cancer Cause and Prevention Research |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | May 07, 2008 Multiple Receipt Dates - See Link to |
Posted Date: | Mar 24, 2006 |
Creation Date: | Apr 10, 2008 |
Archive Date: | May 09, 2008 |
Total Program Funding: | |
Maximum Federal Grant Award: | $200,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | 93.396 -- Cancer Biology Research |
- Applicants Eligible for this Grant
- Special district governments City or township governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Independent school districts Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses State governments Public housing authorities/Indian housing authorities
- Additional Information on Eligibility
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government are eligible to apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster